Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: To Carl Johnson

but so long as the JV is place and the parties are cooperating by the agreed terms, the practical result for licensing is indifferent to actual ownership by PDS.

Soory if I confused anyone, I just use "own" as a short hand reference to PDS's role as a singular controlling entity.

Share
New Message
Please login to post a reply